Polymun Scientific Immunbiologische Forschung GmbH Company Profile
Polymun was founded in 1992 by Prof. Hermann Katinger. It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. These revenues are invested in the proprietary product pipeline and the further development of technology platforms. The R&D projects and technologies are open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals (§63 Austrian Pharmaceutical Law) thus meeting the EU requirements for drug manufacturing. The last inspection has taken place in September 2008.
Competence & Services
The core competence of Polymun is the development and manufacture of biopharmaceuticals, using both mammalian mammalian and microbial cell technology. A fine example are Polymun′s broadly neutralizing HIV-1 antibodies produced in CHO cells. Other examples are recombinant human and porcine trypsin produced in yeast. Cell culture was also the basis for the development of a live attenuated influenza vaccine produced in Vero cells which led to the further investigation in genetically modified influenza viruses used as carrier for foreign epitopes (HIV, TB). Also the innovative liposome technology was initiated in order to optimize the formulation of the pharmacologically potent enzyme SOD, produced by Polymun in E. coli. Today, Polymun can apply this drug delivery platform to all kinds of pharmaceutically active ingredients. The industrial applicability in scale and price is a common focus throughout all projects and technologies.
Location
Donaustr. 99
Klosterneuburg
Vienna
A-3400
Austria
Contact
Phone: +43 2243 25060 303
Fax: +43 2243 25060 399
Email: office@polymun.com
News Articles
CARBOGEN AMCIS and Polymun Scientific GmbH Sign Collaboration Agreement
CARBOGEN AMCIS will Provide Liposomal Formulation for Highly Potent Drugs through Alliance BUBENDORF, Switzerland (October 19, 2011) — Today, Switzerland-based CARBOGEN AMCIS AG,...
Amgen gibt Forschung den Vorzug vor Gewinn
Q4-Überschuss sinkt wegen höhere Aufwendungen für Forschung, Produktion und Marketing von 934 auf 788 Mio Dollar. Artikel bei «Handelsblatt.com» View the story "Amgen gibt Forschung den Vorzug vo...
Evotec-Aktie: Zulassung für französisches Steuerguthaben Forschung
Hamburg - Die Evotec AG (ISIN DE0005664809/ WKN 566480) ist vom französischen Ministerium für Hochschulwesen und Forschung für drei Jahre für das französische Steuerguthaben Forschung akkreditier...
Evotec erhält Zulassung für französisches Steuerguthaben Forschung (CIR)
Evotec erhält Zulassung für französisches Steuerguthaben Forschung (CIR) DGAP-News: Evotec AG / Schlagwort(e): Sonstiges Evotec erhält Zulassung für französisches Steuerguthaben Forschung (CIR)...
Erstes MedAustron Symposium war ein voller Erfolg!
Wiener Neustadt (OTS) – MedAustron, das Zentrum für Ionentherapie und Forschung, veranstaltete sein erstes Symposium über Neuro-Onkologie und nichtklinische Forschung. Das Interesse des wissen...
Klinische Forschung: Panikmache durch Falschaussagen
EU-Verordnungsentwurf sieht Vereinheitlichung vor, zielt aber keineswegs auf ein geringeres Schutzniveau der an klinischen Studien Beteiligten ab. Wien (OTS) – Der EU-Verordnungsentwurf zu klini...
Indische Industrie setzt auf Biotech-Forschung aus Österreich
Während viele Unternehmen Leistungen in Richtung Asien verlagern, gehen zwei indische Unternehmen einen anderen Weg. Sie setzen auf die Forschungsleistung im Austrian Centre of Industrial Biotechnolo...
Pharmig: Tierversuche: Forschung nicht durch bürokratische Hürden gefährden
Wien (OTS) – Innovative Medikamente retten und verbessern Menschenleben. Tierversuche sind entscheidender Bestandteil in der Forschung und Entwicklung. Bürokratische Hürden gefährden den medi...
Drugs and Medications
Oxygen [Pure Process Medical & Scientific Gases, LLC]
oxygen
Aquafresh [GlaxoSmithKline Consumer Healthcare LP]
Drug Facts
Smileguard just 4 me [Dr. Fresh, Inc.]
SmileGuard Just 4 Me Kit
Oralline secure [J.M. Murray Center Inc.]
Despigmen protective 25 [LABORATORIOS DE COSMETICA SCIENTIFICA AT]
DESPIGMEN PROTECTIVE CREAM 25
PubMed Articles
Clinical Trials
The Boston Scientific ENOVUS Trial
A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...
The intent of this protocol is to salvage human-related material that is normally destined for destruction, so it can be used in infection-related scientific studies.
The Boston Scientific ACCESS Trial
The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialys...
Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine
The purpose of this study is to improve the scientific understanding of the cardiovascular actions of cocaine, in particular the ability of cocaine to increase blood pressure.
The intent of this protocol is to salvage human-related material that is normally destined for destruction, so it can be used in infection-related scientific studies. This clinical materia...
Companies
Polymun Scientific Immunbiologische Forschung GmbH
Polymun was founded in 1992 by Prof. Hermann Katinger. It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creatin...
GBF - Gesellschaft für Biotechnologische Forschung mbH
The GBF is an infection research center of the Helmholtz Association, the largest scientific organisation in Germany. Our primary focus is on pathogens which are either medically relevant or which can...
NIL
CorTrial is a professional physician owned and staffed medium sized Contract Research Organisation for the execution and evaluation of clinical trials (phase I – IV) for pharmacological agents as we...
Global Scientific Consulting is well qualified in the planning, design, development, and management of scientific projects; recruiting and teaching/training scientific researchers and technicians; wri...
More Information about "Polymun Scientific Immunbiologische Forschung GmbH" on BioPortfolio
We have published hundreds of Polymun Scientific Immunbiologische Forschung GmbH news stories on BioPortfolio along with dozens of Polymun Scientific Immunbiologische Forschung GmbH Clinical Trials and PubMed Articles about Polymun Scientific Immunbiologische Forschung GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Polymun Scientific Immunbiologische Forschung GmbH Companies in our database. You can also find out about relevant Polymun Scientific Immunbiologische Forschung GmbH Drugs and Medications on this site too.
